Ackerman Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Ackerman Capital Advisors's JNJ Position: Q2 2026 in Review
Ackerman Capital Advisors increased its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2026, buying an estimated $12.4K and bringing the position to 1,966 shares worth $499K. The position accounts for 0.1% of the portfolio, ranked #74.
Ackerman Capital Advisors first reported a position in JNJ in Q2 2017 and has held it in 32 quarters since. The position peaked at $1.55M in Q1 2018. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Ackerman Capital Advisors held 1,966 shares of Johnson & Johnson worth $499K as of Q2 2026.
- Ackerman Capital Advisors bought 53 Johnson & Johnson shares in Q2 2026, an estimated $12.4K.
- Johnson & Johnson made up 0.1% of Ackerman Capital Advisors's portfolio in Q2 2026, its #74 holding.
- Ackerman Capital Advisors first reported a position in Johnson & Johnson in Q2 2017 and has held it in 32 quarters since.
- Ackerman Capital Advisors's Johnson & Johnson position peaked at $1.55M in Q1 2018.
- 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Ackerman Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.